Drugs / AZD5099
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01340183 | May → Dec 2011 | — | AstraZeneca | Suspended | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD5099 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01340183 ↗ |
| Modality | Small molecule | — CHEMBL3314565 ↗ |
| Route | Intravenous | “after intravenous administration of single doses” NCT01340183 ↗ |